Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 'CHIP'ping away at clonal hematopoiesis.

Literature DB >> 27311932

'CHIP'ping away at clonal hematopoiesis.

D C Link¹, M J Walter¹.

Abstract

Entities: Disease

Mesh：

Year: 2016 PMID： 27311932 DOI： 10.1038/leu.2016.130

Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528

× No keyword cloud information.

19 in total

1. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.

Authors: David P Steensma; Rafael Bejar; Siddhartha Jaiswal; R Coleman Lindsley; Mikkael A Sekeres; Robert P Hasserjian; Benjamin L Ebert
Journal: Blood Date: 2015-04-30 Impact factor: 22.113

2. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.

Authors: Max Jan; Thomas M Snyder; M Ryan Corces-Zimmerman; Paresh Vyas; Irving L Weissman; Stephen R Quake; Ravindra Majeti
Journal: Sci Transl Med Date: 2012-08-29 Impact factor: 17.956

3. The origin and evolution of mutations in acute myeloid leukemia.

Authors: John S Welch; Timothy J Ley; Daniel C Link; Christopher A Miller; David E Larson; Daniel C Koboldt; Lukas D Wartman; Tamara L Lamprecht; Fulu Liu; Jun Xia; Cyriac Kandoth; Robert S Fulton; Michael D McLellan; David J Dooling; John W Wallis; Ken Chen; Christopher C Harris; Heather K Schmidt; Joelle M Kalicki-Veizer; Charles Lu; Qunyuan Zhang; Ling Lin; Michelle D O'Laughlin; Joshua F McMichael; Kim D Delehaunty; Lucinda A Fulton; Vincent J Magrini; Sean D McGrath; Ryan T Demeter; Tammi L Vickery; Jasreet Hundal; Lisa L Cook; Gary W Swift; Jerry P Reed; Patricia A Alldredge; Todd N Wylie; Jason R Walker; Mark A Watson; Sharon E Heath; William D Shannon; Nobish Varghese; Rakesh Nagarajan; Jacqueline E Payton; Jack D Baty; Shashikant Kulkarni; Jeffery M Klco; Michael H Tomasson; Peter Westervelt; Matthew J Walter; Timothy A Graubert; John F DiPersio; Li Ding; Elaine R Mardis; Richard K Wilson
Journal: Cell Date: 2012-07-20 Impact factor: 41.582

4. TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms.

Authors: Angela G Fleischman; Karl J Aichberger; Samuel B Luty; Thomas G Bumm; Curtis L Petersen; Shirin Doratotaj; Kavin B Vasudevan; Dorian H LaTocha; Fei Yang; Richard D Press; Marc M Loriaux; Heike L Pahl; Richard T Silver; Anupriya Agarwal; Thomas O'Hare; Brian J Druker; Grover C Bagby; Michael W Deininger
Journal: Blood Date: 2011-08-22 Impact factor: 22.113

5. Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.

Authors: Tetsuichi Yoshizato; Bogdan Dumitriu; Kohei Hosokawa; Hideki Makishima; Kenichi Yoshida; Danielle Townsley; Aiko Sato-Otsubo; Yusuke Sato; Delong Liu; Hiromichi Suzuki; Colin O Wu; Yuichi Shiraishi; Michael J Clemente; Keisuke Kataoka; Yusuke Shiozawa; Yusuke Okuno; Kenichi Chiba; Hiroko Tanaka; Yasunobu Nagata; Takamasa Katagiri; Ayana Kon; Masashi Sanada; Phillip Scheinberg; Satoru Miyano; Jaroslaw P Maciejewski; Shinji Nakao; Neal S Young; Seishi Ogawa
Journal: N Engl J Med Date: 2015-07-02 Impact factor: 91.245

6. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

Authors: R Coleman Lindsley; Brenton G Mar; Emanuele Mazzola; Peter V Grauman; Sarah Shareef; Steven L Allen; Arnaud Pigneux; Meir Wetzler; Robert K Stuart; Harry P Erba; Lloyd E Damon; Bayard L Powell; Neal Lindeman; David P Steensma; Martha Wadleigh; Daniel J DeAngelo; Donna Neuberg; Richard M Stone; Benjamin L Ebert
Journal: Blood Date: 2014-12-30 Impact factor: 22.113

7. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.

Authors: Giulio Genovese; Anna K Kähler; Robert E Handsaker; Johan Lindberg; Samuel A Rose; Samuel F Bakhoum; Kimberly Chambert; Eran Mick; Benjamin M Neale; Menachem Fromer; Shaun M Purcell; Oscar Svantesson; Mikael Landén; Martin Höglund; Sören Lehmann; Stacey B Gabriel; Jennifer L Moran; Eric S Lander; Patrick F Sullivan; Pamela Sklar; Henrik Grönberg; Christina M Hultman; Steven A McCarroll
Journal: N Engl J Med Date: 2014-11-26 Impact factor: 91.245

8. Clinical and biological implications of driver mutations in myelodysplastic syndromes.

Authors: Elli Papaemmanuil; Moritz Gerstung; Luca Malcovati; Sudhir Tauro; Gunes Gundem; Peter Van Loo; Chris J Yoon; Peter Ellis; David C Wedge; Andrea Pellagatti; Adam Shlien; Michael John Groves; Simon A Forbes; Keiran Raine; Jon Hinton; Laura J Mudie; Stuart McLaren; Claire Hardy; Calli Latimer; Matteo G Della Porta; Sarah O'Meara; Ilaria Ambaglio; Anna Galli; Adam P Butler; Gunilla Walldin; Jon W Teague; Lynn Quek; Alex Sternberg; Carlo Gambacorti-Passerini; Nicholas C P Cross; Anthony R Green; Jacqueline Boultwood; Paresh Vyas; Eva Hellstrom-Lindberg; David Bowen; Mario Cazzola; Michael R Stratton; Peter J Campbell
Journal: Blood Date: 2013-09-12 Impact factor: 22.113

9. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.

Authors: T Haferlach; Y Nagata; V Grossmann; Y Okuno; U Bacher; G Nagae; S Schnittger; M Sanada; A Kon; T Alpermann; K Yoshida; A Roller; N Nadarajah; Y Shiraishi; Y Shiozawa; K Chiba; H Tanaka; H P Koeffler; H-U Klein; M Dugas; H Aburatani; A Kohlmann; S Miyano; C Haferlach; W Kern; S Ogawa
Journal: Leukemia Date: 2013-11-13 Impact factor: 11.528

10. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.

Authors: Terrence N Wong; Giridharan Ramsingh; Andrew L Young; Christopher A Miller; Waseem Touma; John S Welch; Tamara L Lamprecht; Dong Shen; Jasreet Hundal; Robert S Fulton; Sharon Heath; Jack D Baty; Jeffery M Klco; Li Ding; Elaine R Mardis; Peter Westervelt; John F DiPersio; Matthew J Walter; Timothy A Graubert; Timothy J Ley; Todd Druley; Daniel C Link; Richard K Wilson
Journal: Nature Date: 2014-12-08 Impact factor: 49.962

24 in total

Review 1. Clinical consequences of clonal hematopoiesis of indeterminate potential.

Authors: David P Steensma
Journal: Hematology Am Soc Hematol Educ Program Date: 2018-11-30

2. Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life.

Authors: Rocio Acuna-Hidalgo; Hilal Sengul; Marloes Steehouwer; Maartje van de Vorst; Sita H Vermeulen; Lambertus A L M Kiemeney; Joris A Veltman; Christian Gilissen; Alexander Hoischen
Journal: Am J Hum Genet Date: 2017-06-29 Impact factor: 11.025

3. Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia.

Authors: Andriana G Kotini; Chan-Jung Chang; Arthur Chow; Han Yuan; Tzu-Chieh Ho; Tiansu Wang; Shailee Vora; Alexander Solovyov; Chrystel Husser; Malgorzata Olszewska; Julie Teruya-Feldstein; Deepak Perumal; Virginia M Klimek; Alexandros Spyridonidis; Raajit K Rampal; Lewis Silverman; E Premkumar Reddy; Elli Papaemmanuil; Samir Parekh; Benjamin D Greenbaum; Christina S Leslie; Michael G Kharas; Eirini P Papapetrou
Journal: Cell Stem Cell Date: 2017-02-16 Impact factor: 24.633

'CHIP'ping away at clonal hematopoiesis.

1. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.

2. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.

3. The origin and evolution of mutations in acute myeloid leukemia.

4. TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms.

5. Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.

6. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

7. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.

8. Clinical and biological implications of driver mutations in myelodysplastic syndromes.

9. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.

10. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.

Review 1. Clinical consequences of clonal hematopoiesis of indeterminate potential.

2. Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life.

3. Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia.

Review 4. Implications of molecular genetic diversity in myelodysplastic syndromes.

Review 5. Therapy-related myeloid neoplasms: when genetics and environment collide.

Review 6. CHIP, ICUS, CCUS and other four-letter words.

7. Young versus old age at diagnosis confers distinct genomic profiles in patients with polycythemia vera.

Review 8. Clinical Implications of Genetic Mutations in Myelodysplastic Syndrome.

9. Clonality in context: hematopoietic clones in their marrow environment.

Review 10. Clinical consequences of clonal hematopoiesis of indeterminate potential.